Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.
|
Addiction
|
1993
|
41.55
|
2
|
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.
|
Arch Intern Med
|
1998
|
16.62
|
3
|
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
|
Hepatology
|
2003
|
16.40
|
4
|
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
|
Hepatology
|
2006
|
10.18
|
5
|
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
|
Arch Intern Med
|
2006
|
9.21
|
6
|
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.
|
Ultrasound Med Biol
|
2003
|
9.19
|
7
|
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
|
Lancet
|
2012
|
6.93
|
8
|
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).
|
Lancet
|
2002
|
5.60
|
9
|
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.
|
J Hepatol
|
2007
|
4.73
|
10
|
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa.
|
Lancet Infect Dis
|
2007
|
3.23
|
11
|
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
|
Clin Infect Dis
|
2008
|
2.32
|
12
|
Chronic hepatitis B.
|
N Engl J Med
|
2002
|
2.28
|
13
|
High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda.
|
Antivir Ther
|
2011
|
2.20
|
14
|
Natural history of chronic hepatitis B in co-infected patients.
|
J Hepatol
|
2005
|
1.77
|
15
|
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.
|
Semin Liver Dis
|
2003
|
1.47
|
16
|
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
|
Carcinogenesis
|
2006
|
1.41
|
17
|
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.
|
Am J Trop Med Hyg
|
2010
|
1.28
|
18
|
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs.
|
Clin Infect Dis
|
2008
|
1.23
|
19
|
HIV, Hepatitis B, and Hepatitis C in Zambia.
|
J Glob Infect Dis
|
2011
|
1.22
|
20
|
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues.
|
AIDS
|
2011
|
1.16
|
21
|
Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
|
AIDS
|
2013
|
1.14
|
22
|
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
|
Liver Int
|
2011
|
1.04
|
23
|
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives.
|
World J Gastroenterol
|
2013
|
1.02
|
24
|
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
|
J Acquir Immune Defic Syndr
|
2013
|
0.98
|
25
|
Human immunodeficiency virus infection and the liver.
|
World J Hepatol
|
2012
|
0.98
|
26
|
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.
|
J Infect Dis
|
2013
|
0.97
|
27
|
Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria.
|
Clin Infect Dis
|
2013
|
0.94
|
28
|
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.
|
J Viral Hepat
|
2011
|
0.94
|
29
|
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy.
|
Antivir Ther
|
2010
|
0.94
|
30
|
Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
|
Semin Liver Dis
|
2012
|
0.89
|
31
|
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.
|
J Acquir Immune Defic Syndr
|
2014
|
0.87
|
32
|
Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia.
|
AIDS Res Hum Retroviruses
|
2013
|
0.82
|